Shares of consumer-friendly telehealth and wellness company Hims & Hers took a hit late last week when the company pulled back the curtain on its first quarterly earnings since going public through a special purpose acquisition company (SPAC) merger.
While the company posted 2020 revenue that beat market expectations, its roughly $16 trading price immediately dipped from about $16 to the $14...
Consumer telehealth and wellness brand Hims & Hers wrapped up its merger with special purpose acquisition company (SPAC) Oaktree Acquisition Tuesday, and today began trading on the New York Stock Exchange.
The deal was first announced in October, and was originally expected to close before the end of its Q4 2020. After Tuesday's approval, the deal has provided Hims with $279.5 million, $205...
GoodRx is continuing to grow its telehealth services, offering a new program that gives discounts on virtual doctor's visits as well as free mail delivery to all of its subscription GoodRx Gold members.
Users will be able to tap into telehealth visits at discounted rates and can see a provider digitally for over 150 conditions, according to the release. The program lets members then transfer...
Consumer wellness and telehealth company Hims could be the next to throw its hat into the public markets.
According to a report from Reuters, the startup is weighing a potential sale to an unnamed special purpose acquisition company (SPAC) – a "blank-check company" that uses the proceeds of an IPO to acquire or merge another business.
The deal would value Hims at over $1 billion, Reuters' sources...
